Development and validation of a nomogram for predicting overall survival to concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma

HIGHLIGHTS

  • who: Chenyu Wang et al. from the Department of Radiotherapy, Anyang Tumor Hospital, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Henan Medical Key Laboratory of Precise Prevention and Treatment of Esophageal Cancer, Anyang, China have published the research work: Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma, in the Journal: BioMed Research International of 14/07/2022

SUMMARY

    Esophageal carcinoma is one of China`s leading five malignant cancers, ranking third among newly diagnosed . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?